Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Genetic and expression evidence supports FTO rs9939609 as a key susceptibility marker for type 2 diabetes and obesity in Thai adults
Related
- Nanotherapy-mediated biased antigen-presenting cell reprogramming supports T cell anergy to prevent type 1 diabetes
- Lymphoid gene expression supports neuroprotective microglia function
- Maintaining cognitive gains in type 2 diabetes: Barriers, supports, and patterns of strategy use
- RNA evidence supports clinical stage antibody drug targets in oncology
- Alveolar macrophage dysfunction as an early determinant of tuberculosis susceptibility in individuals with type 2 diabetes
BibTeX
@article{yaikwawong2026genetic,
title = {{Genetic and expression evidence supports FTO rs9939609 as a key susceptibility marker for type 2 diabetes and obesity in Thai adults}},
author = {Metha Yaikwawong and Khanittha Kamdee and Pornpimon Ek-eudomsuk and Gunya Sittithumcharee and Siwanon Jirawatnotai and Somlak Chuengsamarn},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-77970-z},
url = {https://www.nature.com/articles/s41598-026-77970-z},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Genetic and expression evidence supports FTO rs9939609 as a key susceptibility marker for type 2 diabetes and obesity in Thai adults
AU - Metha Yaikwawong
AU - Khanittha Kamdee
AU - Pornpimon Ek-eudomsuk
AU - Gunya Sittithumcharee
AU - Siwanon Jirawatnotai
AU - Somlak Chuengsamarn
PY - 2026
DA - 2026/10/26
JO - Scientific Reports
DO - 10.1038/s41598-026-77970-z
UR - https://www.nature.com/articles/s41598-026-77970-z
SN - 2045-2322
ER -